Showing 1 to 3 of 3 results


Olaparib Improves Survival Rates for Inherited Breast Cancer
A UK trial found that giving olaparib before surgery to women with early-stage BRCA1 or BRCA2 mutated breast cancer led to 100% survival at 36 months in the treatment group, compared to a 89% survival rate in the control group, potentially benefiting over 1,200 UK women annually.
Olaparib Improves Survival Rates for Inherited Breast Cancer
A UK trial found that giving olaparib before surgery to women with early-stage BRCA1 or BRCA2 mutated breast cancer led to 100% survival at 36 months in the treatment group, compared to a 89% survival rate in the control group, potentially benefiting over 1,200 UK women annually.
Progress
48% Bias Score


Balti's Sanremo Appearance Challenges Beauty Norms Amid Cancer Battle
Italian model Bianca Balti, diagnosed with stage 3C ovarian cancer in September 2023, co-presented at the Sanremo Music Festival, showcasing her post-surgery scar and shaved head to promote self-acceptance and challenge beauty norms.
Balti's Sanremo Appearance Challenges Beauty Norms Amid Cancer Battle
Italian model Bianca Balti, diagnosed with stage 3C ovarian cancer in September 2023, co-presented at the Sanremo Music Festival, showcasing her post-surgery scar and shaved head to promote self-acceptance and challenge beauty norms.
Progress
40% Bias Score

Two Sisters Diagnosed with Aggressive Breast Cancer Within Two Weeks
Two sisters, aged 28 and 32, were diagnosed with stage two triple-negative breast cancer (TNBC) two weeks apart; both carry the BRCA1 gene and emphasize the importance of early detection and genetic testing.

Two Sisters Diagnosed with Aggressive Breast Cancer Within Two Weeks
Two sisters, aged 28 and 32, were diagnosed with stage two triple-negative breast cancer (TNBC) two weeks apart; both carry the BRCA1 gene and emphasize the importance of early detection and genetic testing.
Progress
40% Bias Score
Showing 1 to 3 of 3 results